Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Some rain moving through overnight. Improving Friday. A mainly dry weekend. Kerrie has the detail.....
Gold medallist drops into the Granada Reports studio with Tony Jardine
A mum from Wythenshawe has been told she must get planning permission for her daughter’s playhouse.